Lifetime proteomic profiling of an A30P α-synuclein Drosophila model of Parkinson's disease

被引:29
|
作者
Xun, Zhiyin
Sowell, Rena A.
Kaufman, Thomas C.
Clemmer, David E. [1 ]
机构
[1] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA
[2] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA
关键词
Parkinson's disease; Drosophila; alpha-synuclein; proteomics; liquid chromatography; mass spectrometry; TANDEM MASS-SPECTROMETRY; PROTEIN EXPRESSION; SUBSTANTIA-NIGRA; TYROSINE-HYDROXYLASE; BIOMARKER DISCOVERY; SHOTGUN PROTEOMICS; MELANOGASTER; PEPTIDES; TOXICITY; RECEPTOR;
D O I
10.1021/pr0700504
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A survey of the proteome changes in an A30P alpha-synuclein Drosophila model of Parkinson's disease (PD) in comparison to age-matched controls is presented for seven different ages across the adult lifespan. The data were acquired by a shotgun proteomic approach that involves multidimensional liquid chromatographies coupled to mass spectrometry and database searching techniques. Semi-quantitative analysis to assess relative changes in protein expression between the Drosophila PD model and age-matched controls provides evidence that 28, 19, 12, 5, 7, 23, and 17 proteins are significantly differentially expressed at days 1, 10, 20, 30, 40, 50, and 60, respectively. From the experimental approach employed, it appears that most dysregulated proteins are associated with narrow distributions of ages, such that disease-associated differences change substantially across the lifespan. Previous measurements [J. Proteorn Res. 2007, 6, 348] at days 1, 10, and 30 showed dysregulation of actin cytoskeletal proteins at day 1 and mitochondrial proteins at day 10, suggesting that defects in the actin cytoskeleton and the mitochondria are associated with dopaminergic neuron degeneration in PD. Analysis of the day 20, 40, 50, and 60 animals supports the finding that these cytoskeletal and mitochondrial changes predominate in the youngest (pre-symtomatic and early disease stages) animals. Although studies across many time points appear to be important for characterizing disease state, an understanding of molecular changes at the youngest ages should be most important for addressing causation.
引用
收藏
页码:3729 / 3738
页数:10
相关论文
共 50 条
  • [21] Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice
    Dalfó, E
    Gómez-Isla, T
    Rosa, JL
    Bodelón, MN
    Tejedor, MC
    Barrachina, M
    Ambrosio, S
    Ferrer, I
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (04) : 302 - 313
  • [22] Staging of α-Synuclein in the Olfactory Bulb in a Model of Parkinson's Disease: Cell Types Involved
    Ubeda-Banon, Isabel
    Saiz-Sanchez, Daniel
    de la Rosa-Prieto, Carlos
    Mohedano-Moriano, Alicia
    Fradejas, Noelia
    Calvo, Soledad
    Argandona-Palacios, Lucia
    Garcia-Munozguren, Susana
    Martinez-Marcos, Alino
    MOVEMENT DISORDERS, 2010, 25 (11) : 1701 - 1707
  • [23] Neuropathology of α-synuclein in Parkinson's disease
    Choong, Chi-Jing
    Mochizuki, Hideki
    NEUROPATHOLOGY, 2022, 42 (02) : 93 - 103
  • [24] Agrochemicals, α-Synuclein, and Parkinson's Disease
    Silva, Blanca A.
    Breydo, Leonid
    Fink, Anthony L.
    Uversky, Vladimir N.
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 598 - 612
  • [25] Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein
    Cho, Min-Kyu
    Kim, Hai-Young
    Fernandez, Claudio O.
    Becker, Stefan
    Zweckstetter, Markus
    PROTEIN SCIENCE, 2011, 20 (02) : 387 - 395
  • [26] The A30P α-synuclein mutation decreases subventricular zone proliferation
    Zhang, Xue-Ming
    Anwar, Sabina
    Kim, Yongsoo
    Brown, Jennifer
    Comte, Isabelle
    Cai, Huan
    Cai, Ning-Ning
    Wade-Martins, Richard
    Szele, Francis G.
    HUMAN MOLECULAR GENETICS, 2019, 28 (14) : 2283 - 2294
  • [27] Drosophila: A Model to Study the Pathogenesis of Parkinson's Disease
    Rahul
    Siddique, Yasir Hasan
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2022, 21 (03) : 259 - 277
  • [28] VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease
    Miura, Emiko
    Hasegawa, Takafumi
    Konno, Masatoshi
    Suzuki, Mari
    Sugeno, Naoto
    Fujikake, Nobuhiro
    Geisler, Sven
    Tabuchi, Mitsuaki
    Oshima, Ryuji
    Kikuchi, Akio
    Baba, Toru
    Wada, Keiji
    Nagai, Yoshitaka
    Takeda, Atsushi
    Aoki, Masashi
    NEUROBIOLOGY OF DISEASE, 2014, 71 : 1 - 13
  • [29] A stress-enhanced model for discovery of disease-modifying gene: Ece1-suppresses the toxicity of α-synuclein A30P
    Chen, Alex Yen-Yu
    Tully, Tim
    NEUROBIOLOGY OF DISEASE, 2018, 114 : 153 - 163
  • [30] Magnetic resonance imaging characterization of an α-synuclein model of Parkinson's disease
    Katrib, Chirine
    Hladky, Hector
    Timmerman, Kelly
    Durieux, Nicolas
    Dutheil, Nathalie
    Bezard, Erwan
    Devos, David
    Laloux, Charlotte
    Betrouni, Nacim
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2024, : 7038 - 7057